Merck & Co., Inc. (NYSE:MRK) is aiming to take a lead in responding to the global health challenge that the so-called “superbugs” are posing to modern medicine with its planned acquisition of antibiotics firm Cubist Pharmaceuticals Inc (NASDAQ:CBST). The buy-out deal, estimated to be worth $8.4 billion to $9.5 billion, was announced on Monday, and…
Why Merck & Co Inc (MRK) Still Remains a Good Bet for Investors
Investing in the pharmaceutical sector has always been rewarding and even though some of the companies in your portfolio, like Merck, might be old enough to be called veterans, they are still worthy enough to provide healthy returns. Merck & Co Inc (NYSE:MRK) proved the veracity of its survival skills yet again as it made…
The Primary Holdings of Kokusai Asset Management Co. Ltd: Apple Inc. (AAPL), Merck & Co., Inc. (MRK) and General Electric Company (GE)
Kokusai Asset Management Co. Ltd, a private owned investment firm, is the product of a 1997 merger of Kokusai Investment Trust Management Co., Ltd and Kokusai Invest Management C., Ltd, which were started in existence since 1983 and 1984 respectively. The company is based in Tokyo, Japan, and has offices in London and Okinawa. It…
Merck & Co., Inc. (MRK), The Walt Disney Company (DIS), The Boeing Company (BA): Top 3 Stock Holdings of Abner Herrman & Brock
Abner Herrman & Brock has offered investment services for over three decades and it has a current portfolio of $340 million, as per its recent SEC 13F filing filed on October 9, 2014. Merck & Co., Inc. (NYSE:MRK), The Walt Disney Company (NYSE:DIS), The Boeing Company (NYSE:BA) are among the top three investments of the…